End-stage ankle osteoarthritis causes severe pain and disability. There are no randomized trials comparing the 2 main surgical treatments: total ankle replacement (TAR) and ankle fusion (AF).
Between 6 March 2015 and 10 January 2019, a total of 303 patients were randomly assigned. At 52 weeks, the scores improved for both groups. The adjusted difference showed that TAR improved more than AF, but the difference was not considered clinically or statistically significant. The number of adverse events was similar between groups, but there were more wound healing issues in the TAR group and more thromboembolic events and nonunion in the AF group. The symptomatic nonunion rate for AF was 7%. A post hoc analysis suggested superiority of fixed-bearing TAR over AF.
Author(s) Source
Goldberg AJ, Chowdhury K, Bordea E et al. Annals of Internal Medicine, 12-2022, https://doi.org/10.7326/M22-2058
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. The content usually is shortened to make it understandable for many. Read the linked original text if you are interested. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know